30 March 2026 Punjab Khabarnama Bureau : A new COVID-19 variant, known as BA.3.2 and nicknamed “Cicada,” is spreading across the United States, raising fresh concerns among health experts and the public. While the variant is not currently believed to cause more severe illness, its rapid spread and ability to evade immunity have made it a subject of close monitoring.
BA.3.2 is a subvariant of the Omicron strain of the SARS-CoV-2 virus. It was first identified in South Africa in late 2024 and has since spread to at least 23 countries. In the United States, the variant has been detected in multiple states through clinical testing and wastewater surveillance, indicating a growing presence.
Health experts say one of the key reasons for concern is the variant’s high number of mutations. BA.3.2 carries around 70 to 75 changes in its spike protein—the part of the virus that allows it to enter human cells. These mutations make it more difficult for the immune system to recognize the virus, even in people who have been vaccinated or previously infected.
Because of these genetic differences, current COVID-19 vaccines may be slightly less effective at preventing infection from BA.3.2. However, doctors emphasize that vaccines are still expected to provide strong protection against severe illness, hospitalization, and death. This means that while more people may get infected, the overall severity of cases is unlikely to increase significantly.
One of the most notable features of BA.3.2 is its ability to spread more easily. Experts believe the variant’s immune-evasion capabilities allow it to infect individuals who might otherwise have some level of protection. This could lead to a rise in case numbers, particularly among vulnerable groups such as the elderly, people with chronic illnesses, and those with weakened immune systems.
Despite its rapid spread, there is currently no evidence that BA.3.2 causes more severe disease than previous variants. Most reported cases have been mild to moderate, with symptoms similar to earlier Omicron strains. Common symptoms include sore throat, cough, fever, fatigue, nasal congestion, and body aches. Some patients have also reported a particularly severe sore throat as a distinguishing symptom.
Doctors stress that the situation does not warrant panic but does require vigilance. The variant has been classified as a “Variant Under Monitoring,” meaning health authorities are closely tracking its spread and impact. While it has not yet been designated as a “Variant of Concern,” its potential to drive new waves of infections remains a possibility.
Another important aspect of BA.3.2 is its “stealth” nature. The variant circulated at low levels for months before gaining attention, partly because it did not initially cause large outbreaks. This delayed detection highlights the importance of genomic surveillance and wastewater monitoring in identifying emerging variants early.
Public health experts also warn that complacency could play a major role in the variant’s spread. As many countries have relaxed COVID-19 restrictions and reduced testing, the virus has more opportunities to circulate and evolve. Lower vaccination rates in some populations further increase the risk of outbreaks.
To reduce the risk of infection, doctors recommend continuing basic preventive measures. These include maintaining good hand hygiene, wearing masks in crowded or poorly ventilated areas, staying home when feeling unwell, and keeping vaccinations up to date. For high-risk individuals, booster doses remain especially important.
Testing and early detection also remain key tools in managing the spread. Individuals experiencing symptoms should get tested and isolate if necessary to prevent transmission to others. Health authorities continue to emphasize the importance of community awareness and responsible behavior.
Looking ahead, scientists are closely studying BA.3.2 to better understand its characteristics and potential impact. Research is ongoing to determine how well existing vaccines and treatments work against the variant and whether updates may be needed in the future.
While the emergence of new variants is not unexpected, BA.3.2 serves as a reminder that the COVID-19 pandemic is not entirely over. The virus continues to evolve, and new strains can still pose challenges to public health systems.
In conclusion, the BA.3.2 variant is spreading quickly in the United States due to its ability to evade immunity and infect more people. However, it does not appear to cause more severe illness, and existing vaccines continue to provide protection against serious outcomes. Staying informed, cautious, and prepared remains the best approach as the situation evolves.
Summary
COVID-19 variant BA.3.2 is spreading in the US due to immune evasion but isn’t more severe. Experts urge caution, vaccination, and basic precautions to prevent potential rise in infections.